Search - tctmd.com

Displaying 61 - 80 of 129

Sort: Relevancy | Date

Presentation TCT 2016

Highlights (and my Interpretations) From: SENTINEL

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Alexandra J. Lansky

November 01, 2016

‘Promising’ SENTINEL Cerebral Protection in TAVR Collects Debris but Misses Primary Endpoint

News Conference News TCT 2016

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Shelley Wood

November 01, 2016

Presentation TCT 2016

Complications 3. The Spectrum of Neurologic Events After TAVR: Insights From NeuroARC

Presenter: Neil E. Moat, John G. Webb, Alexandra J. Lansky

October 31, 2016

Presentation TCT 2016

Looking Back Over 25 Years of the Nurse/Tech Symposium

Presenter: Regina Deible, Mary K. Egan, Alexandra J. Lansky

October 30, 2016

News Daily News

Post-TAVR Cognition Improves in Some Patients and Declines in Others, With Few Signposts to Guide the Way

Shelley Wood

September 29, 2016

News Daily News

La Cognición Post-TAVR Mejora en Algunos Pacientes y Desciende en Otros y son Pocas las Señales Orientativas

Shelley Wood

September 29, 2016

News Conference News PCR London Valves 2016

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Shelley Wood

September 22, 2016

News Conference News PCR London Valves 2016

Leaflet Restriction After TAVR: Two Hospitals Tracking Patients Find Similar Rates of the Phenomenon

Shelley Wood

September 20, 2016

News Conference News EuroPCR 2016

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

Shelley Wood

May 20, 2016

Presentation EuroPCR 2016

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

Presenter: Alexandra Lansky

May 20, 2016

News Industry News

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

February 24, 2016

News Conference News CRT 2016

STEMI Mortality Risk Doubled in Women, Even in North America, Europe

Shelley Wood

February 20, 2016

News Industry News

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

December 08, 2015

Presentation TCT 2015

Cerebral Embolic Protection Devices: Triguard Deflector Device Technology Review and DEFLECT III Results

Presenter: Susheel Kodali, Axel Linke, Alexandra J. Lansky

October 14, 2015

News Industry News

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

October 14, 2015

Presentation TCT 2015

Device and Clinical Program Highlights: Micell

Presenter: Pieter C. Smits, Philip M. Urban, Alexandra J. Lansky

October 12, 2015

Presentation TCT 2015

Is Cerebral Protection Necessary?

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Alexandra J. Lansky

October 11, 2015

News Daily News

与预期相反，研究发现冠状动脉微血管功能障碍无性别差异

Yael L. Maxwell

September 23, 2015

News Daily News

En Contra de lo que cabría Esperar, el Estudio No halla Diferencia de Género en la Disfunción Microvascular Coronaria

Yael L. Maxwell

September 23, 2015

News Daily News

Contrary to Expectations, Study Finds No Sex Difference in Coronary Microvascular Dysfunction

Yael L. Maxwell

September 23, 2015

Advertisement

Highlights (and my Interpretations) From: SENTINEL

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Complications 3. The Spectrum of Neurologic Events After TAVR: Insights From NeuroARC

Looking Back Over 25 Years of the Nurse/Tech Symposium

Post-TAVR Cognition Improves in Some Patients and Declines in Others, With Few Signposts to Guide the Way

La Cognición Post-TAVR Mejora en Algunos Pacientes y Desciende en Otros y son Pocas las Señales Orientativas

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Leaflet Restriction After TAVR: Two Hospitals Tracking Patients Find Similar Rates of the Phenomenon

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

STEMI Mortality Risk Doubled in Women, Even in North America, Europe

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

Cerebral Embolic Protection Devices: Triguard Deflector Device Technology Review and DEFLECT III Results

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

Device and Clinical Program Highlights: Micell

Is Cerebral Protection Necessary?

与预期相反，研究发现冠状动脉微血管功能障碍无性别差异

En Contra de lo que cabría Esperar, el Estudio No halla Diferencia de Género en la Disfunción Microvascular Coronaria

Contrary to Expectations, Study Finds No Sex Difference in Coronary Microvascular Dysfunction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content